Institutional Cluster

VOR

Vor Biopharma Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago
Institutional cluster: 5 buyers, 0 sellers (bullish)
Actionable Insight • Neutral

The buying is entirely mega-passive, reflecting index rebalancing rather than active conviction. Monitor for active fund interest (e.g., healthcare-specialist hedge funds or biotech-focused funds) as a stronger signal. The historical T+20 drift for VOR reports is negative on balance, suggesting fading this passive accumulation is the higher-probability trade near term.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
VOR ▲ +77.79% at T+60d
NEUTRAL call ✓ call won +77.79% · α vs SPY +73.39% · entry $14.09 → $25.05
Entry anchored
Jun 10, 03:59 PM ET
via exchange tick
T+1d
+1.92%
call +1.92% · α +1.38%
$14.36
settled 4mo ago
T+5d
+6.60%
call +6.60% · α +6.17%
$15.02
settled 4mo ago
T+20d
+40.17%
call +40.17% · α +38.28%
$19.75
settled 3mo ago
T+60d
+77.79%
call +77.79% · α +73.39%
$25.05
settled 24d ago

Executive Summary

Five mega-passive institutional investors (Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley) collectively more than doubled their VOR positions in Q4 2025, adding $31.8M in new holdings to reach $50.8M total. This is an index-driven rebalancing move, likely reflecting VOR's continued inclusion in growth/small-cap passive mandates, not an active conviction thesis. The net 11% win rate on prior VOR reports at T+20 and negative historical calibration for this segment caution against over-weighting the signal.

Key Financial Metrics

Direction
accumulating
Buy Value
$50.8M
Net Flow
$31.8M

Institutional Positions

Net institutional flow: $31.8M

▲ Buyers (5)

InstitutionActionChangePosition ValueValue Δ
VanguardDOUBLED+632.2%$10.1M$5.0M
BlackRockDOUBLED+1248.5%$6.1M$4.4M
State StreetDOUBLED+905.7%$1.2M$750.0K
FidelityDOUBLED+968.1%$33.0M$21.5M
Morgan StanleyDOUBLED+538.8%$372.0K$155.0K

Key Facts

  • 5 institutions accumulated $31.8M net in VOR during Q4 2025, bringing aggregate holdings to $50.8M
  • Every buyer was a mega-passive fund: Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley
  • All five funds DOUBLED or more their positions (range: +539% to +1249% share increases)
  • Zero institutional sellers detected in this cluster
  • Prior VOR reports have a T+20 win rate of only 11%, with historical net alpha of -2.1% T+20 in this filing segment

Financial Impact

5 institutions accumulated $31.8M in new VOR holdings, increasing total disclosed institutional position value from $19.0M to $50.8M

institutional ownershipfloat concentration

Risk Factors

  • No active or catalyst-driven buyers — all accumulation is passive/index rebalancing, which carries weaker predictive signal
  • 13F data is stale (45-day lag); positions may have already been unwound or adjusted
  • Historical calibration shows negative expected alpha at T+20 for this filing segment

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-VOR-2025-Q4
9 reports for VOR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for VOR — sortable, filterable
TypeNow
Aug 11, 2026
7w ago
Press Release
NEUTRAL ★ 3/10
$23.37 $23.24▼ −0.58%▲ +0.48%—
Jul 9, 2026
12w ago
3
NEUTRAL ★ 2/10
$19.14 $23.67▲ +23.67%▲ +21.24%—
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 3/10
$14.09 $19.75▲ +40.17%▲ +38.28%—
Jun 8, 2026
16w ago
Press Release
BULLISH ★ 7/10
$13.29 $20.10▲ +51.24%▲ +49.61%—
May 7, 2026
21w ago
EFFECT
NEUTRAL ★ 3/10
$16.08 $13.44▼ −16.42%▼ −19.55%—
Apr 27, 2026
22w ago
S-3
NEUTRAL ★ 3/10
$14.38 $14.10▼ −1.95%▼ −7.42%—
Apr 27, 2026
22w ago
DEFA14A
NEUTRAL ★ 2/10
$14.38 $14.10▼ −1.95%▼ −7.42%—
Mar 27, 2026
27w ago
Press Release
NEUTRAL ★ 5/10
$14.48 $14.12▼ −2.49%▼ −15.23%—
Mar 23, 2026
27w ago
Press Release
NEUTRAL ★ 3/10
$12.15 $15.32▲ +26.09%▲ +17.19%—
Showing 9 of 9

US Market Status

Market Open — Closes in 3h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 11, 2026